KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Opko Health (OPK) Net Income towards Common Stockholders (2016 - 2025)

Historic Net Income towards Common Stockholders for Opko Health (OPK) over the last 16 years, with Q3 2025 value amounting to $21.6 million.

  • Opko Health's Net Income towards Common Stockholders fell 1309.2% to $21.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$180.4 million, marking a year-over-year decrease of 3488.96%. This contributed to the annual value of -$53.2 million for FY2024, which is 7181.23% up from last year.
  • Latest data reveals that Opko Health reported Net Income towards Common Stockholders of $21.6 million as of Q3 2025, which was down 1309.2% from -$148.4 million recorded in Q2 2025.
  • In the past 5 years, Opko Health's Net Income towards Common Stockholders registered a high of $31.1 million during Q1 2021, and its lowest value of -$148.4 million during Q2 2025.
  • Its 5-year average for Net Income towards Common Stockholders is -$41.8 million, with a median of -$55.4 million in 2022.
  • Per our database at Business Quant, Opko Health's Net Income towards Common Stockholders surged by 15274.92% in 2021 and then plummeted by 134061.53% in 2025.
  • Over the past 5 years, Opko Health's Net Income towards Common Stockholders (Quarter) stood at -$73.3 million in 2021, then dropped by 16.23% to -$85.2 million in 2022, then grew by 21.98% to -$66.5 million in 2023, then skyrocketed by 121.12% to $14.0 million in 2024, then soared by 54.11% to $21.6 million in 2025.
  • Its Net Income towards Common Stockholders stands at $21.6 million for Q3 2025, versus -$148.4 million for Q2 2025 and -$67.6 million for Q1 2025.